US Pharma MarketingKardigan itching for IPO to fund late-stage cardiovascular pipeline
Kardigan itching for IPO to fund late-stage cardiovascular pipeline is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Kardigan may have only launched last year, but it seems the cardiovascular-focused biotech is already eyeing the public markets.
Source: FierceBiotech